Global Peripheral Vascular Stents Market Size Study & Forecast, by Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), by Mode of Delivery (Self-expanding Stents, Balloon-expandable Stents), by Product (Iliac Artery Stents, Femoral Artery

Global Peripheral Vascular Stents Market Size Study & Forecast, by Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), by Mode of Delivery (Self-expanding Stents, Balloon-expandable Stents), by Product (Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Other Peripheral Stents), by End-use, and Regional Analysis, 2023-2030

Global Peripheral Vascular Stents Market is valued at approximately USD 1.67 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2023-2030. A peripheral vascular stent is a medical device designed to treat narrowed or blocked blood vessels in the peripheral arteries, which are located outside the heart and brain. These arteries supply blood to the limbs, including the legs, arms, and pelvis. It is used to treat Peripheral Artery Disease (PAD)a condition that results in narrowing of the arteries that supply blood to the legs, arms, and other parts of the body. The rise in incidences of PAD, increasing awareness of PAD among healthcare professionals and the population, and the rising number of government initiatives are the most prominent factors that are fueling the market demand across the globe.

Additionally, the growing geriatric population is exhibiting a positive influence on market growth during the estimated period. The aging population is more prone to develop vascular diseases, including PAD. As per the United Nations, there were 703 million people aged 65 years or over in the world in 2019. The number of older people is projected to double to 1.5 billion in 2050. As a result, with the increasing elderly population, the demand for peripheral vascular stents also rises, which is accelerating the market expansion worldwide. Moreover, growing investment in the advancements in stent technology, as well as the increasing focus on the development of healthcare infrastructure presents various lucrative opportunities over the forecast years. However, the high cost of procedures and the availability of other treatment options are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Peripheral Vascular Stents Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of a well-established healthcare infrastructure that includes advanced healthcare facilities. Peripheral vascular stents are easily accessible to patients in the region because of this advanced medical infrastructure, which aids in the diagnosis and treatment of CVDs. For instance, according to the Centers for Disease Control and Prevention latest report released in October 2022, a heart attack arises in the United States every 40 seconds, and every year, 805,000 Americans are estimated to have a heart attack. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Factors such as sedentary lifestyles, unhealthful eating patterns, and an aging population, all contribute to the rising prevalence of illnesses such as PAD. Accordingly, the need for efficient therapeutic alternatives such as peripheral vascular stents is increasing. Moreover, the increasing geographical expansion of the key market players and technological advancements in the field of peripheral vascular stents are significantly propelling the market demand across the region.

Major market players included in this report are:
Boston Scientific Corporation
Medtronic
Terumo Medical Corporation
Abbott
Biotronik
Lifetech Corporation
iVascular SLU
Stryker Corporation
Cook Medical
Microport Scientific Corporation

Recent Developments in the Market:
 In October 2022, Cordis declared that the company plan to acquire MedAlliance, a Swiss company renowned for its avant-garde drug-eluting balloons. The company aims to increase its worldwide footprint and provide possible therapy to almost two million patients by 2027 by using MedAlliance's innovative SELUTION SLR (Sustained Limus Release) drug-eluting balloon.

Global Peripheral Vascular Stents Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, Mode of Delivery, Product, End-use, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents

By Mode of Delivery:
Self-expanding Stents
Balloon-expandable Stents

By Product:
Iliac Artery Stents
Femoral Artery Stents
Carotid Artery Stents
Renal Artery Stents
Other Peripheral Stents

By End-use:
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Boston Scientific Corporation
Medtronic
Terumo Medical Corporation
Abbott
Biotronik
Lifetech Corporation
iVascular SLU
Stryker Corporation
Cook Medical
Microport Scientific Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.